Stocks
Nektar Therapeutics (NKTR) EV/EBITDA US GAAP (year values) |
||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
| EV/EBITDA | ? | -5.39 | -4.07 | -0.15 | -0.15 | -0.14 | 0.24 | |
| Changes by years, y/y, % | -28% | -24% | -96% | +0% | -8% | |||
Nektar Therapeutics. EV/EBITDA
Nektar Therapeutics. EV/EBITDA, changes, %
Nektar Therapeutics (NKTR) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | 1.00 | -0.26 | -0.96 | -1.42 | -0.96 | 0.24 | |
| Changes by years, y/y, % | -272% | +14% | -173% | -207% | -195% | |||
| Changes by quarters, q/q, % | -24% | -126% | +268% | +48% | -33% | |||
